Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masna Rai

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Expert Opinion on Investigational Drugs|May 13, 2025
A randomized, double-blind, single dose, parallel group, 2-arm study assessing the pharmacokinetic similarity, pharmacodynamic, safety, tolerability, and immunogenicity profiles of biosimilar candidate AVT03 (60 mg/mL) in healthy male adultsAnel Pretorius, Felicitas Bullo, Lukasz Jaskiewicz, et al.
Expert Opinion on Biological Therapy|June 13, 2025
A randomized, double-masked parallel-group, multicenter clinical study evaluating the efficacy and safety of the biosimilar candidate AVT06 compared to the reference product aflibercept in participants with neovascular age-related macular degenerationHansjürgen Agostini, Kristine Baumane, Vilma Jūratė Balčiūnienė, et al.
Expert Opinion on Biological Therapy|July 23, 2025
A randomized, double blind, parallel design, repeat dose, 2-arm, multicenter study comparing the efficacy, safety, immunogenicity, and pharmacokinetic profiles of a denosumab biosimilar, AVT03, in postmenopausal women with osteoporosisMamuka Lortkipanidze, Tobie de Villiers, Grzegorz Kania, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 10, 2025
Pharmacokinetic Similarity of Biosimiliar AVT05 Versus Reference Product Golimumab in Healthy Adults: A Double-Blind, Three-Arm, Parallel-Group StudyChris Wynne, Ulrike Lorch, Edrich Krantz, et al.
The Science of the Total Environment|February 12, 2021
A systematic review on the association between total and cardiopulmonary mortality/morbidity or cardiovascular risk factors with long-term exposure to increased or decreased ambient temperatureSofia Zafeiratou, Evangelia Samoli, Konstantina Dimakopoulou, et al.
Environment International|August 21, 2023
Assessment of short-term heat effects on cardiovascular mortality and vulnerability factors using small area data in EuropeSiqi Zhang, Susanne Breitner, Masna Rai, et al.
Environment International|March 19, 2023
Heat-related cardiorespiratory mortality: Effect modification by air pollution across 482 cities from 24 countriesMasna Rai, Massimo Stafoggia, Francesca de'Donato, et al.
Environment International|October 14, 2023
Joint effect of heat and air pollution on mortality in 620 cities of 36 countriesMassimo Stafoggia, Paola Michelozzi, Alexandra Schneider, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Expert Opinion on Investigational Drugs|May 13, 2025
A randomized, double-blind, single dose, parallel group, 2-arm study assessing the pharmacokinetic similarity, pharmacodynamic, safety, tolerability, and immunogenicity profiles of biosimilar candidate AVT03 (60 mg/mL) in healthy male adultsAnel Pretorius, Felicitas Bullo, Lukasz Jaskiewicz, et al.
Expert Opinion on Biological Therapy|June 13, 2025
A randomized, double-masked parallel-group, multicenter clinical study evaluating the efficacy and safety of the biosimilar candidate AVT06 compared to the reference product aflibercept in participants with neovascular age-related macular degenerationHansjürgen Agostini, Kristine Baumane, Vilma Jūratė Balčiūnienė, et al.
Expert Opinion on Biological Therapy|July 23, 2025
A randomized, double blind, parallel design, repeat dose, 2-arm, multicenter study comparing the efficacy, safety, immunogenicity, and pharmacokinetic profiles of a denosumab biosimilar, AVT03, in postmenopausal women with osteoporosisMamuka Lortkipanidze, Tobie de Villiers, Grzegorz Kania, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 10, 2025
Pharmacokinetic Similarity of Biosimiliar AVT05 Versus Reference Product Golimumab in Healthy Adults: A Double-Blind, Three-Arm, Parallel-Group StudyChris Wynne, Ulrike Lorch, Edrich Krantz, et al.
The Science of the Total Environment|February 12, 2021
A systematic review on the association between total and cardiopulmonary mortality/morbidity or cardiovascular risk factors with long-term exposure to increased or decreased ambient temperatureSofia Zafeiratou, Evangelia Samoli, Konstantina Dimakopoulou, et al.
Environment International|August 21, 2023
Assessment of short-term heat effects on cardiovascular mortality and vulnerability factors using small area data in EuropeSiqi Zhang, Susanne Breitner, Masna Rai, et al.
Environment International|March 19, 2023
Heat-related cardiorespiratory mortality: Effect modification by air pollution across 482 cities from 24 countriesMasna Rai, Massimo Stafoggia, Francesca de'Donato, et al.
Environment International|October 14, 2023
Joint effect of heat and air pollution on mortality in 620 cities of 36 countriesMassimo Stafoggia, Paola Michelozzi, Alexandra Schneider, et al.
Pageof 2